(Q88292103)

English

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

scientific article published on 09 March 2020

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit